Jerome I Tokars1, Sonja J Olsen1, Carrie Reed1. 1. Influenza Division, National Centers for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
Background: The seasonal incidence of influenza is often approximated as 5%-20%. Methods: We used 2 methods to estimate the seasonal incidence of symptomatic influenza in the United States. First, we made a statistical estimate extrapolated from influenza-associated hospitalization rates for 2010-2011 to 2015-2016, collected as part of national surveillance, covering approximately 9% of the United States, and including the existing mix of vaccinated and unvaccinated persons. Second, we performed a literature search and meta-analysis of published manuscripts that followed cohorts of subjects during 1996-2016 to detect laboratory-confirmed symptomatic influenza among unvaccinated persons; we adjusted this result to the US median vaccination coverage and effectiveness during 2010-2016. Results: The statistical estimate of influenza incidence among all ages ranged from 3.0%-11.3% among seasons, with median values of 8.3% (95% confidence interval [CI], 7.3%-9.7%) for all ages, 9.3% (95% CI, 8.2%-11.1%) for children <18 years, and 8.9% (95% CI, 8.2%-9.9%) for adults 18-64 years. Corresponding values for the meta-analysis were 7.1% (95% CI, 6.1%-8.1%) for all ages, 8.7% (95% CI, 6.6%-10.5%) for children, and 5.1% (95% CI, 3.6%-6.6%) for adults. Conclusions: The 2 approaches produced comparable results for children and persons of all ages. The statistical estimates are more versatile and permit estimation of season-to-season variation. During 2010-2016, the incidence of symptomatic influenza among vaccinated and unvaccinated US residents, including both medically attended and nonattended infections, was approximately 8% and varied from 3% to 11% among seasons.
Background: The seasonal incidence of influenza is often approximated as 5%-20%. Methods: We used 2 methods to estimate the seasonal incidence of symptomatic influenza in the United States. First, we made a statistical estimate extrapolated from influenza-associated hospitalization rates for 2010-2011 to 2015-2016, collected as part of national surveillance, covering approximately 9% of the United States, and including the existing mix of vaccinated and unvaccinated persons. Second, we performed a literature search and meta-analysis of published manuscripts that followed cohorts of subjects during 1996-2016 to detect laboratory-confirmed symptomatic influenza among unvaccinated persons; we adjusted this result to the US median vaccination coverage and effectiveness during 2010-2016. Results: The statistical estimate of influenza incidence among all ages ranged from 3.0%-11.3% among seasons, with median values of 8.3% (95% confidence interval [CI], 7.3%-9.7%) for all ages, 9.3% (95% CI, 8.2%-11.1%) for children <18 years, and 8.9% (95% CI, 8.2%-9.9%) for adults 18-64 years. Corresponding values for the meta-analysis were 7.1% (95% CI, 6.1%-8.1%) for all ages, 8.7% (95% CI, 6.6%-10.5%) for children, and 5.1% (95% CI, 3.6%-6.6%) for adults. Conclusions: The 2 approaches produced comparable results for children and persons of all ages. The statistical estimates are more versatile and permit estimation of season-to-season variation. During 2010-2016, the incidence of symptomatic influenza among vaccinated and unvaccinated US residents, including both medically attended and nonattended infections, was approximately 8% and varied from 3% to 11% among seasons.
Authors: J M Langley; F Aoki; B J Ward; A McGeer; J B Angel; G Stiver; I Gorfinkel; D Shu; L White; B Lasko; P Dzongowski; K Papp; M Alexander; G Boivin; L Fries Journal: Vaccine Date: 2011-01-08 Impact factor: 3.641
Authors: Arnold S Monto; Suzanne E Ohmit; Joshua G Petrie; Emileigh Johnson; Rachel Truscon; Esther Teich; Judy Rotthoff; Matthew Boulton; John C Victor Journal: N Engl J Med Date: 2009-09-24 Impact factor: 91.245
Authors: Suzanne E Ohmit; Joshua G Petrie; Ryan E Malosh; Emileigh Johnson; Rachel Truscon; Barbara Aaron; Casey Martens; Caroline Cheng; Alicia M Fry; Arnold S Monto Journal: J Infect Dis Date: 2015-11-23 Impact factor: 5.226
Authors: Matthew Biggerstaff; Krista Kniss; Daniel B Jernigan; Lynnette Brammer; Joseph Bresee; Shikha Garg; Erin Burns; Carrie Reed Journal: Am J Epidemiol Date: 2018-05-01 Impact factor: 4.897
Authors: Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia Journal: Clin Infect Dis Date: 2019-03-05 Impact factor: 9.079
Authors: Kai Sing Sun; Tai Pong Lam; Kit Wing Kwok; Kwok Fai Lam; Dan Wu; Pak Leung Ho Journal: Hum Vaccin Immunother Date: 2020-01-24 Impact factor: 3.452
Authors: Jianling Xie; Xiao-Li Pang; Gillian A M Tarr; Yuan Mu; Ran Zhuo; Linda Chui; Bonita E Lee; Otto G Vanderkooi; Phillip I Tarr; Samina Ali; Shannon E MacDonald; Stephen B Freedman Journal: J Clin Virol Date: 2020-08-01 Impact factor: 3.168
Authors: Jeremy C Jones; Philippe Noriel Q Pascua; Thomas P Fabrizio; Bindumadhav M Marathe; Patrick Seiler; Subrata Barman; Richard J Webby; Robert G Webster; Elena A Govorkova Journal: Proc Natl Acad Sci U S A Date: 2020-03-26 Impact factor: 11.205
Authors: Mbayame Nd Niang; Jonathan D Sugimoto; Aldiouma Diallo; Bou Diarra; Justin R Ortiz; Kristen D C Lewis; Kathryn E Lafond; M Elizabeth Halloran; Marc-Alain Widdowson; Kathleen M Neuzil; John C Victor Journal: Clin Infect Dis Date: 2021-06-15 Impact factor: 9.079
Authors: Carlos Lerner; Christina Albertin; Alejandra Casillas; O Kenrik Duru; Michael K Ong; Sitaram Vangala; Sharon Humiston; Sharon Evans; Michael Sloyan; Craig R Fox; Jonathan E Bogard; Sarah Friedman; Peter G Szilagyi Journal: Pediatrics Date: 2021-08 Impact factor: 7.124